- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Teva Investigational Site 165 Tucson, Arizona, United States
- Teva Investigational Site 167 Little Rock, Arkansas, United States
- Teva Investigational Site 11 Corona, California, United States
- Teva Investigational Site 21 Fountain Valley, California, United States
Clinical trial condition
Mantle Cell Lymphoma
Explore clinical trials studying Mantle Cell Lymphoma. Study availability and eligibility vary by location and protocol.
251 public trials
59 recruiting studies
Mantle Cell Lymphoma trial results
Completed
A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers
NCT01460134
- Conditions
- Adenocarcinoma, Adnexal Diseases, Any T-cell Malignancy, +70 more
- Locations
-
- Mayo Clinic Arizona - Cancer Clinical Research Unit Scottsdale, Arizona, United States
- Stanford Cancer Center - Stanford University Stanford, California, United States
- Mayo Clinic Rochester, Minnesota, United States
- Icahn School of Medicine at Mount Sinai Hess Center for Science and Medicine New York, United States
NCT02142530
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Diffuse Large B-cell Lymphoma, +27 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Beth-Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
NCT01646021
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Antwerp, Belgium
- Bruges, Belgium
- Brussels, Belgium
- Edegem, Belgium
NCT01562977
- Conditions
- Aggressive Lymphoma, Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- Hospital Germans Trias i Pujol Badalona, Barcelona, Spain
- Hospital Duran i Reynals Sabadell, Barcelona, Spain
- Hospital SAS de Jerez Jerez de la Frontera, Cádiz, Spain
- Hospital Dr. Jose Molina Orosa Arrecife, Lanzarote, Spain
NCT01399840
- Conditions
- Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +24 more
- Locations
-
- Indiana University Simon Cancer Center Indianapolis, Indiana, United States
- Seattle Cancer Care Alliance Seattle, Washington, United States
- University of Wisconsin Madison, Wisconsin, United States
- University College London London, United Kingdom
Completed
Temsirolimus, Bendamustine and Rituximab for Relapsed Follicular Lymphoma or Mantle Cell Lymphoma
NCT01078142
- Conditions
- Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- Universitätsmedizin Mainz Mainz, Rhineland-Palatinate, Germany
NCT00472420
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- National Institute of Oncology, A Dept of Internal Medicine Budapest, Hungary
- University of Debrecen Medical and Health Science Center, Institute of Internal Medicine, Hematology Debrecen, Hungary
- Petz Aladar Megyei Korhaz; Hematologia Győr, Hungary
- Kaposi Mor Teaching Hospital, Dept of Internal Medicine/Hematology Kaposvár, Hungary
NCT00075478
- Conditions
- Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Aggressive Non-Hodgkin Lymphoma, +48 more
- Locations
-
- OHSU Cancer Institute-Southern Region Medford, Oregon, United States
- Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
- LDS Hospital Salt Lake City, Utah, United States
- VA Puget Sound Health Care System Seattle, Washington, United States
Completed
Study of Intravenously Administered SNS-032 in Patients With Advanced B-lymphoid Malignancies
NCT00446342
- Conditions
- B-Lymphoid Malignancies, Blood Protein Disorders, Cardiovascular Diseases, +29 more
- Locations
-
- City of Hope Duarte, California, United States
- Stanford Cancer Center Stanford, California, United States
- Winship Cancer Institute at Emory University Atlanta, Georgia, United States
- Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States